Graham Capital Management, L.P.

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1315421 ROWAYTON, CT

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$679,123

+$445,305 QoQ

Shares Held

2,256

+283.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#437

of 764 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. ALNY ranks #5 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	446,696	$25,376,799
2	INCY	Incyte Corp	15,632	$1,772,043
3	IONS	Ionis Pharmaceuticals Inc	16,717	$1,325,490
4	VKTX	Viking Therapeutics, Inc.	22,114	$862,667
5	ALNY	Alnylam Pharmaceuticals, Inc. This page	2,256	$679,123
6	ARVN	Arvinas, Inc.	81,364	$676,134
7	PCVX	Vaxcyte, Inc.	11,107	$645,649
8	MRVI	Maravai Lifesciences Holdings, Inc.	92,277	$575,808

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$679,123	2,256	+283.7%	Shares	Sole	2026-08-14
2025-12-31	$233,818	588	-80.5%	Shares	Sole	2026-02-17
2025-09-30	$1,374,840	3,015	-4.3%	Shares	Sole	2025-11-14
2025-06-30	$1,027,183	3,150	+64.9%	Shares	Sole	2025-08-14
2025-03-31	$515,738	1,910	-18.7%	Shares	Sole	2025-05-15
2024-12-31	$552,978	2,350	-34.9%	Shares	Sole	2025-02-14
2024-09-30	$992,858	3,610	+45.6%	Shares	Sole	2024-11-14
2024-06-30	$602,640	2,480	-70.0%	Shares	Sole	2024-08-14
2024-03-31	$1,234,905	8,263	+479.0%	Shares	Sole	2024-05-15
2023-09-30	$252,721	1,427	-19.3%	Shares	Sole	2023-11-22
2023-06-30	$336,003	1,769	-85.2%	Shares	Sole	2023-08-14
2022-09-30	$2,389,910	11,940	-17.5%	Shares	Sole	2022-11-14
2022-06-30	$2,109,720	14,465	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.